Condition: Hypertension · Blood Pressure · Cardiovascular Diseases · Sponsor: Suzhou Municipal Hospital
This seamless two-stage phase II/III clinical trial aims to evaluate the efficacy and safety of a novel focused power ultrasound mediated inferior perirenal adipose tissue modification therapy for essential hypertension. Stage 1 is a phase II, multicenter, open-label, randomized trial to determine the optimal treatment strategy. Stage 2 is a phase III, multicenter, randomized, double-blind trial investigating the efficacy and safety of optimal treatment strategy compared to sham control.
This description comes directly from the study's public registry record.
Yanhui Sheng · 13851647530 · yhsheng@njmu.edu.cn
Yang Hua · 13851624359 · 759150674@qq.com
Always discuss trial participation with your own doctor first.
| The Affiliated Jiangning Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| The first Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Affiliated Hospital of Nantong University | Nantong, Jiangsu, China | Recruiting |
| Suzhou Municipal Hospital | Suzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06283758